ICON's 2026 High-Single-Digit Growth Potential Intact If Customer Hurdles Cleared, UBS Says

USA
EnglishUK
EnglishIndia
EnglishAustralia
EnglishCanada
EnglishFrance
FrançaisSuisse
FrançaisEspaña
EspañolDeutschland
DeutschÖsterreich
DeutschSchweiz
DeutschBelgië
NederlandsNederland
NederlandsItalia
ItalianoSverige
Svenska
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
182.96 USD | -1.91% |
|
-6.82% | -12.94% |
10:24am | Truist Securities Adjusts Price Target on ICON to $262 From $284, Keeps Buy Rating | MT |
Jan. 30 | Icon Portfolio of Ai Tools Drives Clinical Trial Efficiencies | CI |